Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Japanese doctor testifies on inflating placebo counts in Diovan trials
Fierce Pharma Asia
Tue, 03/17/15 - 07:13 pm
Tags:
Japan, Diovan, Novartis
Novartis Pays $12.6M Fine for Giving Inaccurate Pricing Data to Medicare
WSJ Pharmalot
Mon, 03/16/15 - 03:00 pm
Tags:
Novartis, Sandoz, Medicare
Novartis AG (ADR) Cosentyx More Effective Than Johnson & Johnson Stelara
Bidness Etc.
Sat, 03/14/15 - 03:04 pm
Tags:
Novartis, Cosentyx, Stelara, JNJ, psoriasis
Cost watchdogs back Novartis' Xolair for big new market in chronic hives
Fierce Pharma
Thu, 03/12/15 - 09:36 pm
Tags:
Novartis, Xolair, chronic hives, UK, NICE
Novartis CEO eyes more cost cuts to satisfy margin demands
Fierce Pharma
Mon, 03/9/15 - 11:46 am
Tags:
Novartis, Joe Jimenez, Pharma CEOs
First-ever bio-generic drug doesn’t help Novartis shares
Marketwatch
Sun, 03/8/15 - 10:20 am
Tags:
biologics, Novartis, Neupogen, Zarxio
First Copycat Biotech Drug Spurs $250B Obamacare Savings
Forbes
Sat, 03/7/15 - 11:16 am
Tags:
Zarxio, Novartis, biologics, Amgen, Neupogen
Is AbbVie (ABBV) Giving Up On Hepatitis C Market Due To Tough Competition From Gilead (GILD)?
Bidness Etc.
Sat, 03/7/15 - 11:07 am
Tags:
AbbVie, hepatitis C, Gilead Sciences, JNJ, Pfizer, Novartis
Novartis gets bragging rights on first U.S. biosim. But will its Neupogen copy sell?
Fierce Pharma
Fri, 03/6/15 - 11:27 am
Tags:
Novartis, Neupogen, Zarxio, biosimilars sector
Novartis wins approval for first U.S. biosimilar drug
Yahoo/Reuters
Fri, 03/6/15 - 10:01 am
Tags:
Novartis, FDA, Neupogen, Zarxio, Sandoz, Amgen
Novartis sells its RNAi cast-offs from Alnylam in $35M fire sale to Arrowhead
Fierce Biotech
Thu, 03/5/15 - 08:21 am
Tags:
Novartis, Alnylam, RNAi, Arrowhead Research
Novartis CEO: We can rebuild our good name after 'reputational hit' in Japan
Fierce Pharma
Tue, 03/3/15 - 01:23 pm
Tags:
Novartis, Joe Jimenez, Japan
GlaxoSmithKline plc (ADR) And Novartis AG (ADR) Complete Three-Part Deal To Restructure
Bidness Etc.
Mon, 03/2/15 - 08:11 am
Tags:
Novartis, GSK, M&A, vaccines, oncology
Novartis AG, Amgen, Inc. Tussle Over Neupogen Biosimilar Continues
Bidness Etc.
Sun, 03/1/15 - 11:40 am
Tags:
Novartis, Amgen, biosimilars, Neupogen
Novartis treatment for vision loss meets goals in study
Yahoo/Reuters
Fri, 02/27/15 - 07:11 pm
Tags:
Novartis, Alcon, RTH258, wet age-related macular degeneration
Novartis AG (ADR) Ordered To Halt Some Japanese Operations
Bidness Etc.
Fri, 02/27/15 - 02:04 pm
Tags:
Novartis, Japan
Novartis looks to squelch neuro worries over its would-be cardio blockbuster
Fierce Biotech
Fri, 02/27/15 - 11:37 am
Tags:
Novartis, LCZ696
Novartis lung cancer drug gets EU recommendation
Yahoo/Reuters
Fri, 02/27/15 - 09:09 am
Tags:
Novartis, Europe, Zykadia, ALK inhibitors, lung cancer
GSK to be No. 1 vaccine producer when it completes $25B asset swap with Novartis next week
Bizjournals.com
Wed, 02/25/15 - 04:39 pm
Tags:
GSK, Novartis, vaccines
Pharmacyclics mulls sale; J&J, Novartis interested - Bloomberg
Yahoo/Reuters
Wed, 02/25/15 - 04:27 pm
Tags:
Pharmacyclics, JNJ, Novartis, M&A

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.